132 related articles for article (PubMed ID: 20699661)
21. Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation.
Wetzler M; Brady MT; Tracy E; Li ZR; Donohue KA; O'Loughlin KL; Cheng Y; Mortazavi A; McDonald AA; Kunapuli P; Wallace PK; Baer MR; Cowell JK; Baumann H
Clin Cancer Res; 2006 Nov; 12(22):6817-25. PubMed ID: 17121903
[TBL] [Abstract][Full Text] [Related]
22. Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide.
Goussetis DJ; Gounaris E; Wu EJ; Vakana E; Sharma B; Bogyo M; Altman JK; Platanias LC
Blood; 2012 Oct; 120(17):3555-62. PubMed ID: 22898604
[TBL] [Abstract][Full Text] [Related]
23. Combination of Arsenic trioxide and Everolimus (Rad001) synergistically induces both autophagy and apoptosis in prostate cancer cells.
Tai S; Xu L; Xu M; Zhang L; Zhang Y; Zhang K; Zhang L; Liang C
Oncotarget; 2017 Feb; 8(7):11206-11218. PubMed ID: 28061438
[TBL] [Abstract][Full Text] [Related]
24. Arsenic trioxide preferentially induces nonapoptotic cell deaths as well as actin cytoskeleton rearrangement in the CHO AA8 cell line.
Izdebska M; Klimaszewska-Wiśniewska A; Lewandowski D; Marcin Nowak J; Gagat M; Grzanka A
Postepy Hig Med Dosw (Online); 2014 Dec; 68():1492-500. PubMed ID: 25531713
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
[TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GADD expression.
Li X; Ding X; Adrian TE
Pancreas; 2003 Aug; 27(2):174-9. PubMed ID: 12883267
[TBL] [Abstract][Full Text] [Related]
27. Factors determining sensitivity and resistance of tumor cells to arsenic trioxide.
Sertel S; Tome M; Briehl MM; Bauer J; Hock K; Plinkert PK; Efferth T
PLoS One; 2012; 7(5):e35584. PubMed ID: 22590507
[TBL] [Abstract][Full Text] [Related]
28. Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.
Li X; Ding X; Adrian TE
Cancer Invest; 2004; 22(3):389-400. PubMed ID: 15493360
[TBL] [Abstract][Full Text] [Related]
29. Autophagy modification augmented the treatment effects initiated by arsenic trioxide in NB4 cells.
Ren Y; Xie Y; Chai L; Wang S; Cheng M
Med Oncol; 2011 Mar; 28(1):231-6. PubMed ID: 20107931
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of action of arsenic trioxide.
Miller WH; Schipper HM; Lee JS; Singer J; Waxman S
Cancer Res; 2002 Jul; 62(14):3893-903. PubMed ID: 12124315
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide induces programmed cell death through stimulation of ER stress and inhibition of the ubiquitin-proteasome system in human sarcoma cells.
Chiu HW; Tseng YC; Hsu YH; Lin YF; Foo NP; Guo HR; Wang YJ
Cancer Lett; 2015 Jan; 356(2 Pt B):762-72. PubMed ID: 25449439
[TBL] [Abstract][Full Text] [Related]
32. Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53.
Karlsson J; Øra I; Pörn-Ares I; Påhlman S
Clin Cancer Res; 2004 May; 10(9):3179-88. PubMed ID: 15131059
[TBL] [Abstract][Full Text] [Related]
33. Signal transduction pathways and transcription factors triggered by arsenic trioxide in leukemia cells.
Sumi D; Shinkai Y; Kumagai Y
Toxicol Appl Pharmacol; 2010 May; 244(3):385-92. PubMed ID: 20193703
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of ID2 antagonizes arsenic trioxide-induced antitumor effects in cancer cells.
Zhang X; Lv C; Du B; Ma X; Guan J; Gao S; Li X; Zheng L; Lei L
Tumori; 2014; 100(3):352-7. PubMed ID: 25076250
[TBL] [Abstract][Full Text] [Related]
35. Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk.
Zhu Q; Zhang JW; Zhu HQ; Shen YL; Flexor M; Jia PM; Yu Y; Cai X; Waxman S; Lanotte M; Chen SJ; Chen Z; Tong JH
Blood; 2002 Feb; 99(3):1014-22. PubMed ID: 11807007
[TBL] [Abstract][Full Text] [Related]
36. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
Zheng T; Yin D; Lu Z; Wang J; Li Y; Chen X; Liang Y; Song X; Qi S; Sun B; Xie C; Meng X; Pan S; Liu J; Jiang H; Liu L
Mol Cancer; 2014 May; 13():133. PubMed ID: 24884809
[TBL] [Abstract][Full Text] [Related]
37. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.
Kanzawa T; Kondo Y; Ito H; Kondo S; Germano I
Cancer Res; 2003 May; 63(9):2103-8. PubMed ID: 12727826
[TBL] [Abstract][Full Text] [Related]
38. Arsenic Trioxide inhibits the growth of human ovarian carcinoma cell line.
Bornstein J; Sagi S; Haj A; Harroch J; Fares F
Gynecol Oncol; 2005 Dec; 99(3):726-9. PubMed ID: 16243384
[TBL] [Abstract][Full Text] [Related]
39. The conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC7901 human gastric cancer cells.
Zheng Y; Zhou M; Ye A; Li Q; Bai Y; Zhang Q
World J Surg Oncol; 2010 Apr; 8():31. PubMed ID: 20403207
[TBL] [Abstract][Full Text] [Related]
40. Ebb-and-flow of macroautophagy and chaperone-mediated autophagy in Raji cells induced by starvation and arsenic trioxide.
Li CL; Wei HL; Chen J; Wang B; Xie B; Fan LL; Li LJ
Asian Pac J Cancer Prev; 2014; 15(14):5715-9. PubMed ID: 25081691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
